IFNβ-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: A longitudinal 1-year study

  1. Aristimuño, C.
  2. de Andrés, C.
  3. Bartolomé, M.
  4. de las Heras, V.
  5. Martínez-Ginés, Ma.L.
  6. Arroyo, R.
  7. Fernández-Cruz, E.
  8. Sánchez-Ramón, S.
Journal:
Clinical Immunology

ISSN: 1521-6616 1521-7035

Year of publication: 2010

Volume: 134

Issue: 2

Pages: 148-157

Type: Article

DOI: 10.1016/J.CLIM.2009.09.008 GOOGLE SCHOLAR

Sustainable development goals